Q3 2023 Haemonetics Corp Earnings Call Transcript
Good day, and welcome to the Haemonetics Third Quarter Fiscal '23 Conference Call and Webcast. (Operator Instructions) As a reminder, this call is being recorded. I would now like to turn the call over to David Trenk, Manager-Investor Relations. You may begin.
Good morning, everyone. Thank you for joining us for Haemonetics Third Quarter Fiscal '23 Conference Call and Webcast. I'm joined today by Chris Simon, our CEO; Roy Galvin, President of our Global Plasma and Blood Center businesses; and James D'Arecca, our CFO. This morning, we posted our third quarter and year-to-date fiscal '23 results to our Investor Relations website, along with updates to our fiscal '23 guidance and the analytical tables with the information that we will refer to on this call. Unless otherwise noted, all revenue growth rates we will discuss today are organic and exclude the impact of currency fluctuation, strategic exits of product lines, acquisitions and divestitures.Â
Additionally, to help investors understand Haemonetics' ongoing business performance, we will
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |